472 related articles for article (PubMed ID: 25540092)
1. Etiological classification of depression based on the enzymes of tryptophan metabolism.
Fukuda K
BMC Psychiatry; 2014 Dec; 14():372. PubMed ID: 25540092
[TBL] [Abstract][Full Text] [Related]
2. A link between stress and depression: shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression.
Miura H; Ozaki N; Sawada M; Isobe K; Ohta T; Nagatsu T
Stress; 2008 May; 11(3):198-209. PubMed ID: 18465467
[TBL] [Abstract][Full Text] [Related]
3. The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression.
Maes M; Leonard BE; Myint AM; Kubera M; Verkerk R
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr; 35(3):702-21. PubMed ID: 21185346
[TBL] [Abstract][Full Text] [Related]
4. Tryptophan kynurenine metabolism as a common mediator of genetic and environmental impacts in major depressive disorder: the serotonin hypothesis revisited 40 years later.
Oxenkrug GF
Isr J Psychiatry Relat Sci; 2010; 47(1):56-63. PubMed ID: 20686200
[TBL] [Abstract][Full Text] [Related]
5. Monitoring tryptophan metabolism in chronic immune activation.
Schröcksnadel K; Wirleitner B; Winkler C; Fuchs D
Clin Chim Acta; 2006 Feb; 364(1-2):82-90. PubMed ID: 16139256
[TBL] [Abstract][Full Text] [Related]
6. Inflammation and serotonin deficiency in major depressive disorder: molecular docking of antidepressant and anti-inflammatory drugs to tryptophan and indoleamine 2,3-dioxygenases.
Dawood S; Bano S; Badawy AA
Biosci Rep; 2022 May; 42(5):. PubMed ID: 35506370
[TBL] [Abstract][Full Text] [Related]
7. [New developments on the serotonin hypothesis of depression: shunt of tryptophan].
Marazziti D; Baroni S; Picchetti M; Piccinni A; Silvestri S; Dell'Osso L
Riv Psichiatr; 2013; 48(1):23-34. PubMed ID: 23438698
[TBL] [Abstract][Full Text] [Related]
8. A new theory of depression based on the serotonin/kynurenine relationship and the hypothalamicpituitary- adrenal axis.
Ramírez LA; Pérez-Padilla EA; García-Oscos F; Salgado H; Atzori M; Pineda JC
Biomedica; 2018 Sep; 38(3):437-450. PubMed ID: 30335249
[TBL] [Abstract][Full Text] [Related]
9. Interaction of the immune-inflammatory and the kynurenine pathways in rats resistant to antidepressant treatment in model of depression.
Duda W; Curzytek K; Kubera M; Connor TJ; Fagan EM; Basta-Kaim A; Trojan E; Papp M; Gruca P; Budziszewska B; Leśkiewicz M; Maes M; Lasoń W
Int Immunopharmacol; 2019 Aug; 73():527-538. PubMed ID: 31176083
[TBL] [Abstract][Full Text] [Related]
10. Indoleamine-2,3-Dioxygenase/Kynurenine Pathway as a Potential Pharmacological Target to Treat Depression Associated with Diabetes.
da Silva Dias IC; Carabelli B; Ishii DK; de Morais H; de Carvalho MC; Rizzo de Souza LE; Zanata SM; Brandão ML; Cunha TM; Ferraz AC; Cunha JM; Zanoveli JM
Mol Neurobiol; 2016 Dec; 53(10):6997-7009. PubMed ID: 26671617
[TBL] [Abstract][Full Text] [Related]
11. [Depression and inflammation in rheumatic diseases].
Buras A; Waszkiewicz N; Szulc A
Postepy Hig Med Dosw (Online); 2016 Mar; 70():162-8. PubMed ID: 26943313
[TBL] [Abstract][Full Text] [Related]
12. Late developmental stage-specific role of tryptophan hydroxylase 1 in brain serotonin levels.
Nakamura K; Sugawara Y; Sawabe K; Ohashi A; Tsurui H; Xiu Y; Ohtsuji M; Lin QS; Nishimura H; Hasegawa H; Hirose S
J Neurosci; 2006 Jan; 26(2):530-4. PubMed ID: 16407550
[TBL] [Abstract][Full Text] [Related]
13. Role of the indoleamine-2,3-dioxygenase/kynurenine pathway of tryptophan metabolism in behavioral alterations in a hepatic encephalopathy rat model.
Jiang X; Xu L; Tang L; Liu F; Chen Z; Zhang J; Chen L; Pang C; Yu X
J Neuroinflammation; 2018 Jan; 15(1):3. PubMed ID: 29301550
[TBL] [Abstract][Full Text] [Related]
14. Cytokine regulation of tryptophan metabolism in the hypothalamic-pituitary-adrenal (HPA) axis: implications for protective and toxic consequences in neuroendocrine regulation.
Tu H; Rady PL; Juelich T; Smith EM; Tyring SK; Hughes TK
Cell Mol Neurobiol; 2005 Jun; 25(3-4):673-80. PubMed ID: 16075385
[TBL] [Abstract][Full Text] [Related]
15. Network beyond IDO in psychiatric disorders: revisiting neurodegeneration hypothesis.
Myint AM; Kim YK
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():304-13. PubMed ID: 24184687
[TBL] [Abstract][Full Text] [Related]
16. Suppression of Kynurenine 3-Monooxygenase as a Treatment for Triple-negative Breast Carcinoma.
Sordillo LA; Sordillo PP
Anticancer Res; 2023 Dec; 43(12):5275-5282. PubMed ID: 38030171
[TBL] [Abstract][Full Text] [Related]
17. [Diagnoses and new therapeutic strategy focused on physiological alteration of tryptophan metabolism].
Mouri A; Hasegawa M; Kunisawa K; Saito K; Nabeshima T
Nihon Yakurigaku Zasshi; 2023 May; 158(3):233-237. PubMed ID: 36990795
[TBL] [Abstract][Full Text] [Related]
18. Predominant expression of tryptophan hydroxylase 1 mRNA in the pituitary: a postmortem study in human brain.
Zill P; Büttner A; Eisenmenger W; Müller J; Möller HJ; Bondy B
Neuroscience; 2009 Apr; 159(4):1274-82. PubMed ID: 19233335
[TBL] [Abstract][Full Text] [Related]
19. The association between the hypothalamic pituitary adrenal axis and tryptophan metabolism in persons with recurrent major depressive disorder and healthy controls.
Sorgdrager FJH; Doornbos B; Penninx BWJH; de Jonge P; Kema IP
J Affect Disord; 2017 Nov; 222():32-39. PubMed ID: 28668713
[TBL] [Abstract][Full Text] [Related]
20. The Role of the Kynurenine Signaling Pathway in Different Chronic Pain Conditions and Potential Use of Therapeutic Agents.
Jovanovic F; Candido KD; Knezevic NN
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
